Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...
In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...
MiniMax plans to price its Hong Kong initial public offering at the top of the marketed range, people familiar with the matter said, reflecting investor enthusiasm for Chinese startups that are ...
Chinese AI company MiniMax is expected to price its Hong Kong IPO at the top of its range and raise about $538M, Reuters reported, citing three people familiar with the matter. At the higher end, the ...
MiniMax is set to raise at least HK$4.2 billion (US$537.7 million) by pricing its Hong Kong initial public offering (IPO) at the top of its marketed range, underscoring strong demand for China's ...
HONG KONG/SINGAPORE, Jan 5 (Reuters) - MiniMax Group is expected to price its Hong Kong IPO at the top of a marketing range and raise $538 million, three people with knowledge of the deal said, in the ...
Chip maker AMD is getting into the mini PC business… sort of. The new AMD Ryzen Halo is a compact desktop computer with AMD branding. But it’s not really designed for the general public. Instead, it’s ...
The Alibaba-backed firm is set to price its 25.4 million shares at HK$165 each, the top end of its marketed range, sources say MiniMax is set to raise at least HK$4.2 billion (US$537.7 million) by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results